Performance of the OraQuick Rapid Antibody Test for Diagnosis of Human Immunodeficiency Virus Type 1 Infection in Patients with Various Levels of Exposure to Highly Active Antiretroviral Therapy
Open Access
- 1 May 2003
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 41 (5), 2153-2155
- https://doi.org/10.1128/jcm.41.5.2153-2155.2003
Abstract
With oral mucosal transudate and serum samples from 101 human immunodeficiency virus type 1 (HIV-1)-infected subjects and 100 HIV-1-negative volunteers, the OraQuick HIV-1 test demonstrated 100% specificity and 96% sensitivity. Four false-negative subjects, who were characterized by early initiation of effective antiretroviral therapy, demonstrated waning serum anti-gp41 titers and Western blot band intensities.Keywords
This publication has 15 references indexed in Scilit:
- Selective Increases in HIV-Specific Neutralizing Antibody and Partial Reconstitution of Cellular Immune Responses during Prolonged, Successful Drug Therapy of HIV InfectionAIDS Research and Human Retroviruses, 2001
- Routinely recommended HIV testing at an urban urgent-care clinic--Atlanta, Georgia, 2000.2001
- Rapid Voluntary Testing and Counseling for HIV: Acceptability and Feasibility in Zambian Antenatal Care ClinicsAnnals of the New York Academy of Sciences, 2000
- Simple/rapid test devices for anti-HIV screening: do they come up to the mark?1999
- Postexposure Chemoprophylaxis for Occupational Exposures to the Human Immunodeficiency VirusJAMA, 1999
- Failure to Learn Human Immunodeficiency Virus Test Results in Los Angeles Public Sexually Transmitted Disease ClinicsSexually Transmitted Diseases, 1998
- HIV-1 Antigen–specific and –nonspecific B Cell Responses Are Sensitive to Combination Antiretroviral TherapyThe Journal of Experimental Medicine, 1998
- Update: HIV counseling and testing using rapid tests--United States, 1995.1998
- On-site HIV testing in resource-poor settingsAIDS, 1997